Entia Biosciences, Inc.
Entia Biosciences, Inc. (ERGO) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
ergo · pe ratio · data through Dec 31, 2016
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Entia Biosciences, Inc. (ERGO) measures how much investors pay for each dollar of the company's trailing earnings. ERGO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.
Source: FMP · /ratios-ttm · /analyst-estimates · 2016-12-31
PE Ratio History
2007 – 2016 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Entia Biosciences, Inc.You ERGO | $0M | N/A | — | -$0.05 |
 AVAX Technologies, Inc. AVXT | $0M | N/A | — | -$0.05 |
 Bangi Inc. BNGI | $0M | N/A | — | -$0.15 |
 Biostax Corp. BTAX | $0M | N/A | — | -$0.03 |
 Better Therapeutics, Inc. BTTX | $0M | N/A | — | -$1.69 |
 DNAPrint Genomics, Inc. DNAG | $0M | N/A | — | -$0.03 |
 Panacos Pharmaceuticals, Inc. PANC | $0M | N/A | — | -$0.70 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2016-12-31Latest FY2016 | — | $-0.05 | — | |
2015-12-31 FY2015 | — | $-0.10 | — | |
2014-12-31 FY2014 | — | $-0.28 | — | |
2013-12-31 FY2013 | — | $-0.43 | — | |
2012-12-31 FY2012 | — | $-0.21 | — | |
2011-12-31 FY2011 | — | $-0.28 | — | |
2010-12-31 FY2010 | — | $-0.24 | — | |
2009-12-31 FY2009 | — | $-0.14 | — | |
2008-12-31 FY2008 | — | $-0.04 | — | |
2007-12-31 FY2007 | — | $-0.00 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Entia Biosciences, Inc. (ERGO) measures how much investors pay for each dollar of the company's trailing earnings. ERGO's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.05.
Frequently asked questions
ERGO pe ratio · 6 questionsERGO's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.05. Data sourced from Financial Modeling Prep via ERGO's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Entia Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09